LyophilisedLIR
Liraglutide
Bulk≥99.5% Purity
Pharmaceutical-grade liraglutide for daily GLP-1 receptor agonist therapy in weight management.
Request a Quote
Pricing available for qualified medical professionals, clinics, and distributors.
Enquire NowDownload MonographView FAQMechanism of Action
Liraglutide shares 97% sequence homology with native human GLP-1. A C-16 fatty acid (palmitic acid) enables albumin binding for a half-life of ~13 hours, allowing once-daily dosing. It activates GLP-1 receptors to enhance glucose-dependent insulin secretion, suppress glucagon, and promote satiety.
Clinical Benefits
- GLP-1 receptor agonist with daily dosing
- Supports appetite regulation and satiety
- Well-established clinical safety profile
- Approved for weight management and glycaemic control
Specifications
MechanismGLP-1 receptor agonist
Half-life~13 hours (daily dosing)
Purity≥99.5%
Storage & Handling
- Store at 2–8°C
- Protect from light
For professional medical use only. Not for retail sale to the general public. Pricing available on request for qualified medical institutions and distributors.